Sublime

Engineered plasma cells as a long-term biologic drug delivery platform 🧬 We're starting to make pretty advanced biologic therapies. Bi-specific T-cell engagers (BiTEs) are a great example. Let's look at Blinatumomab, a BiTE approved to treat B-cell acute lymphoblastic leukemia (B-ALL). This... See more